(SRPT) Sarepta Therapeutics - Performance -49.2% in 12m
Compare SRPT with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-43.13%
#64 in Group
Rel. Strength
12.01%
#7041 in Universe
Total Return 12m
-49.21%
#110 in Group
Total Return 5y
-51.29%
#62 in Group
P/E 23.1
59th Percentile in Group
P/E Forward 7.09
40th Percentile in Group
PEG 159
100th Percentile in Group
FCF Yield -6.71%
67th Percentile in Group
12m Total Return: SRPT (-49.2%) vs XBI (-6.5%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
-8.25% | 25.2% | 163% | 11.9 | 10.6 | 1.43 | 83.8% | 78.5% |
HLN NYSE Haleon |
0.89% | 22.3% | 40.6% | 24.7 | 20.3 | 1.8 | 27.1% | - |
AMGN NASDAQ Amgen |
-11.6% | 4.69% | 33.7% | 36.6 | 13.3 | 0.94 | -18.8% | -20% |
LONN SW Lonza |
-1.09% | 7.58% | 35.2% | 60.7 | 31.7 | 1.15 | 12.6% | -10.3% |
BIM PA Biomerieux |
-2.83% | 12.9% | -1.51% | 31 | 24.2 | 1.45 | -58.7% | -25.1% |
KMDA NASDAQ Kamada |
-7.32% | 33% | -9.75% | 24.3 | 22.8 | 0.91 | 47.7% | 3.93% |
ERF PA Eurofins Scientific SE |
9.29% | -9.24% | 24.2% | 24.3 | 11.7 | 0.58 | -70.8% | -17.1% |
GRFS NASDAQ Grifols |
-7.23% | 11% | -64% | 26.9 | 11 | 0.23 | -45.4% | -33.9% |
Performance Comparison: SRPT vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for SRPT
Total Return (including Dividends) | SRPT | XBI | S&P 500 |
---|---|---|---|
1 Month | -22.06% | -10.94% | -6.73% |
3 Months | -50.07% | -14.92% | -11.93% |
12 Months | -49.21% | -6.46% | 7.24% |
5 Years | -51.29% | -19.21% | 100.61% |
Trend Score (consistency of price movement) | SRPT | XBI | S&P 500 |
1 Month | -60.0% | -52.8% | -63.5% |
3 Months | -97.4% | -92.8% | -90.3% |
12 Months | -75.5% | -32.4% | 60.6% |
5 Years | 6.20% | -53.3% | 84.2% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #155 | -12.5% | -16.4% |
3 Month | #172 | -41.3% | -43.3% |
12 Month | #110 | -45.7% | -52.6% |
5 Years | #62 | -39.7% | -75.7% |
FAQs
Does SRPT Sarepta Therapeutics outperforms the market?
No,
over the last 12 months SRPT made -49.21%, while its related Sector, the SPDR S&P Biotech (XBI) made -6.46%.
Over the last 3 months SRPT made -50.07%, while XBI made -14.92%.
Over the last 3 months SRPT made -50.07%, while XBI made -14.92%.
Performance Comparison SRPT vs Indeces and Sectors
SRPT vs. Indices SRPT is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 8.43% | -15.3% | -47.4% | -56.5% |
US NASDAQ 100 | QQQ | 7.95% | -14.7% | -47.6% | -56.8% |
US Dow Jones Industrial 30 | DIA | 10.5% | -15.2% | -48.1% | -53.7% |
German DAX 40 | DAX | 7.21% | -18.1% | -67.3% | -69.5% |
Shanghai Shenzhen CSI 300 | CSI 300 | 9.0% | -18.7% | -48.6% | -58.4% |
Hongkong Hang Seng | HSI | 5.76% | -18.3% | -52.0% | -66.0% |
India NIFTY 50 | INDA | 6.28% | -24.1% | -50.8% | -52.2% |
Brasil Bovespa | EWZ | 4.16% | -22.5% | -52.5% | -40.5% |
SRPT vs. Sectors SRPT is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 7.72% | -15.2% | -56.6% | -64.3% |
Consumer Discretionary | XLY | 6.99% | -15.2% | -52.7% | -60.5% |
Consumer Staples | XLP | 8.28% | -25.0% | -55.4% | -60.5% |
Energy | XLE | 8.36% | -9.56% | -46.1% | -36.5% |
Financial | XLF | 7.73% | -17.2% | -56.3% | -67.0% |
Health Care | XLV | 10.7% | -14.3% | -45.2% | -46.8% |
Industrial | XLI | 9.03% | -16.0% | -47.3% | -53.3% |
Materials | XLB | 8.69% | -16.2% | -40.2% | -43.3% |
Real Estate | XLRE | 8.66% | -18.8% | -47.1% | -63.9% |
Technology | XLK | 8.16% | -13.1% | -41.2% | -50.4% |
Utilities | XLU | 8.54% | -22.3% | -51.1% | -70.9% |
Aerospace & Defense | XAR | 9.88% | -18.9% | -56.8% | -71.1% |
Biotech | XBI | 5.01% | -11.1% | -36.0% | -42.8% |
Homebuilder | XHB | 6.90% | -13.9% | -32.7% | -38.7% |
Retail | XRT | 6.56% | -16.7% | -44.0% | -42.9% |